We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Pfizer’s New Meningitis Vaccine Trumenba
FDA Approves Pfizer’s New Meningitis Vaccine Trumenba
The FDA approved under its breakthrough therapy designation pathway Pfizer’s meningitis vaccine Trumenba, the first vaccine to prevent a deadly strain of meningococcal disease.